(-)-Pindolol increases dialysate concentrations of dopamine and noradrenaline, but not serotonin, in the frontal cortex of freely-moving rats

Neuropharmacology

Volumn 38, Issue 6, 1999, Pages 909-912

  Millan, M J ^a   Gobert, A ^a  

^a INSTITUT DE RECHERCHES INTERNATIONALES SERVIER   (France)

Author keywords

( ) Pindolol; Dialysis; Frontal cortex; Monoamines

Indexed keywords

DOPAMINE; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; NORADRENALIN; PINDOLOL; PROPRANOLOL; SEROTONIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CONTROLLED STUDY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; RAT; SEROTONINERGIC SYSTEM; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; DIALYSIS; DOPAMINE; FRONTAL LOBE; MALE; MOVEMENT; NOREPINEPHRINE; PINDOLOL; RATS; RATS, WISTAR; SEROTONIN;

EID: 0032917388     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0028-3908(99)00012-X     Document Type: Article

References (10)

1. 1A autoreceptor in vivo. Br. J. Pharmacol. 124:1998;206-212.
2. 1A receptor antagonist and an SSRI in vivo: effects on 5-HT cell firing and extracellular 5-HT. Br. J. Pharmacol. 115:1995;1064-1070.
3. Gobert A., Rivet J.-M., Audinot V., Newman-Tancredi A., Cistarelli L., Millan M.J. Simultaneous quantification of serotonin, dopamine and noradrenaline levels in single frontal cortex dialysates of freely-moving rats reveals a complex pattern of reciprocal auto- and hetero- receptor mediated control of release. Neuroscience. 84:1998;413-429.
4. Hjorth S. (-)-Pindolol, but not buspirone potentiates the citalopram-induced rise in extracellular 5-hydroxytryptamine. Eur. J. Pharmacol. 303:1996;183-186.
5. Kaur P., Ahlenius S. Potentiation of DOI-induced forward locomotion in rats by (-)-pindolol pretreatment. J. Neural. Transm. 104:1997;605-614.
6. McAskill R., Mir S., Taylor D. Pindolol augmentation of antidepressant therapy. Br. J. Psychiatry. 173:1998;203-208.
7. 2-adrenergic receptors. Life Sci. 57:1995;327-332.
8. 1A receptors. Neuropsychopharmacology. 18:1998;395-398.
9. Tanda G., Carboni E., Frau R., Di Chiara G. Increase of extracellular dopamine in the prefrontal cortex: a trait of drugs with antidepressant potential? Psychopharmacology. 115:1994;285-288.
10. Zohar J., Lere B., Belmaker R.H. Beta-2 adrenergic agonists for depression as a potential treatment. Zohar J., Belmaker R.H. Treating resistant depression. 1987;375-380 PMA publishing, New York.